Chédiak–Higashi syndrome presenting as a hereditary spastic paraplegia

被引:0
作者
Kishin Koh
Mai Tsuchiya
Hiroyuki Ishiura
Haruo Shimazaki
Takeshi Nakamura
Hideo Hara
Kohei Suzuyama
Makio Takahashi
Shoji Tsuji
Yoshihisa Takiyama
机构
[1] University of Yamanashi,Department of Neurology, Graduate School of Medical Sciences
[2] The University of Tokyo,Department of Neurology
[3] Saitama Medical University,Faculty of Health & Medical Care
[4] Saitama Medical University Hospital,Department of Neurology
[5] Kyoto Takeda Hospital,Department of Neurology
[6] Saga University Faculty of Medicine,Division of Neurology, Department of Internal Medicine
[7] The Tazuke-Kofukai,Department of Neurology, Kitano Hospital Medical Research Institute
[8] The University of Tokyo,Department of Molecular Neurology, Graduate School of Medicine
[9] International University of Health and Welfare,Institute of Medical Genomics
来源
Journal of Human Genetics | 2022年 / 67卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Hereditary spastic paraplegias (HSPs) comprise a group of neurodegenerative disorders characterized by weakness and leg spasticity. LYST is responsible for Chédiak–Higashi syndrome (CHS), which exhibits partial oculocutaneous albinism, primary immunodeficiency, and bleeding tendency in childhood. Although neurological symptoms of CHS also appear in adulthood, a phenotype of spastic paraplegia has rarely been reported in CHS. In this study, we investigated LYST mutations in 387 HSP patients through the Japan Spastic Paraplegia Research Consortium to clarify the frequency of LYST mutations in HSP, finding six adult patients with LYST mutations in four HSP families. They exhibited intellectual disability, cerebellar ataxia, neuropathy, and pyramidal signs. Meanwhile, only 15 patients with CHS in childhood have been revealed in a decade by a nationwide survey in Japan. Thus, LYST mutations might indicate a HSP phenotype in a considerable number of adult patients with CHS.
引用
收藏
页码:119 / 121
页数:2
相关论文
共 75 条
  • [1] Salinas S(2008)Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms Lancet Neurol 7 1127-38
  • [2] Proukakis C(2014)Autosomal-recessive complicated spastic paraplegia with a novel lysosomal trafficking regulator gene mutation J Neurol Neurosurg Psychiatry 85 1024-8
  • [3] Crosby A(2020)A case of late-onset Chediak-Higashi syndrome with progressive gait disturbance and cognitive dysfunction caused by novel variant in LYST gene. Neurol Clin Neurosci 8 415-8
  • [4] Warner TT(2018)JASPAC: Japan Spastic Paraplegia Research Consortium Brain Sci 8 153-43
  • [5] Shimazaki H(2020)The mutational constraint spectrum quantified from variation in 141,456 humans Nature 581 434-11
  • [6] Honda J(2001)dbSNP: the NCBI database of genetic variation Nucleic Acids Res 29 308-53
  • [7] Naoi T(2016)Human Genetic Variation Database, a reference database of genetic variations in the Japanese population J Hum Genet 61 547-9
  • [8] Namekawa M(2010)A method and server for predicting damaging missense mutations Nat Methods 7 248-6
  • [9] Nakano I(2012)Predicting the functional effect of amino acid substitutions and indels PLoS One 7 e46688-7
  • [10] Yazaki M(2021)CADD-splice-improving genome-wide variant effect prediction using deep learning-derived splice scores Genome Med 13 1582-58